Green Alpha Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
QFMHK
BSWM
TWM
GI
FFA
EP
ATC
TWD
Green Alpha Advisors's DNA Position: Q3 2026 in Review
Green Alpha Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 13,546 shares — an estimated $134K sold.
Green Alpha Advisors first reported a position in DNA in Q1 2023 and held it in 14 quarters. The position peaked at $515K in Q3 2023. 9 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Green Alpha Advisors reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
- Green Alpha Advisors sold 13,546 Ginkgo Bioworks shares in Q3 2026, an estimated $134K.
- Green Alpha Advisors first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 14 quarters.
- Green Alpha Advisors's Ginkgo Bioworks position peaked at $515K in Q3 2023.
- 9 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.